Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

RADXRADX
2 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in Radiopharm Theranostics

RHUMBLINE ADVISERS holds 121 shares of RADX (Radiopharm Theranostics), worth $519 as of 2026-Q1. The position was increased (+1916.7% shares).

Current Value

$519

Current Shares

121

Total Value Change

+$488

Total Shares Change

+115

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
121
+1916.7%
$5190.0%$4.86
12
2025-Q4
New
6
-
$310.0%$5.16
17

Other major holders of RADX: HSBC HOLDINGS PLC, UBS Group AG, PNC FINANCIAL SERVICES GROUP, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used